Abstract:BACKGROUND & OBJECTIVE:Increasing evidences showed that circulating tumor metastasis related factors could be detected, and it is related to tumor stage, and prognosis. This study was to investigate the correlation of serum vascular endothelial growth factor (sVEGF), CD44 standard (CD44s), and matrix metalloproteinase-3 (MMP-3) level to the clinical outcomes in nasopharyngeal carcinoma (NPC)patients.METHODS:Forty-six NPC patients without metastasis, 20 NPC patients with local recurrence and/or distant metastasis,and 28 healthy controls entered this study. Serum VEGF, CD44s, and MMP-3 protein were quantitatively analyzed by enzyme-link immunosorbent assay (ELISA).RESULTS:The mean level of sVEGF in metastatic NPC was (791.7+/-560.5) ng/L, which was significantly higher than that in NPC patients without metastasis [(429.0+/-249.7) ng/L], and healthy controls [(424.6+/-197.1) ng/L], whereas there was no significant difference between NPC patients without metastasis and healthy controls. In primary NPC patients, sVEGF level in NPC of stage T4 were significantly higher than those in NPC of stage T1-T3. Moreover, 2-year disease-free survival rate in patients with sVEGF level of more than 600 ng/L was significantly lower than that in patients with sVEGF Level of less than 600 ng/L (37.5% vs 83.9%). The serum level of MMP-3 in NPC patients with metastasis [(28.8+/-15.5)microg/L] was significantly higher than that in patients without metastasis [(19.8+/-11.6) microg/L], and healthy controls [(16.2+/-11.1) microg/L], but there was no significant difference between NPC patients without metastasis and healthy controls. Though the serum level of CD44s in NPC patients (including patients with or without metastasis) was higher than that in healthy controls, there was no significant difference between NPC patients with and without metastasis. No correlation was observed between serum MMP-3, CD44s level and clinical outcomes of NPC.CONCLUSION:Our results indicate that when the sVEGF level are >or= 800 ng/L and/or serum MMP-3 level >or= 30 microg/L in NPC patients, local recurrence or distant metastasis would occur. In primary NPC patients without metastasis, sVEGF level is correlate with primary tumor progression, moreover, sVEGF level of >or= 600 ng/L before treatment predicate lower 2-year disease-free survival rate.

Serum CCL2 and Serum TNF-α – Two New Biomarkers Predict Bone Invasion, Post-Treatment Distant Metastasis and Poor Overall Survival in Nasopharyngeal Carcinoma

High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations

Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study

Correlation Of Five Secretory Proteins With The Nasopharyngeal Carcinoma Metastasis And The Clinical Applications

Extensive Serum Biomarker Analysis in Patients with Nasopharyngeal Carcinoma.

A Prognostic Model Predicts the Risk of Distant Metastasis and Death for Patients with Nasopharyngeal Carcinoma Based on Pre-Treatment Serum C-reactive Protein and N-classification.

Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays

The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study

Evaluation Of The Prognostic Value Of Tgf-Beta Superfamily Type I Receptor And Tgf-Beta Type Ii Receptor Expression In Nasopharyngeal Carcinoma Using High-Throughput Tissue Microarrays

[Clinical Significance of Quantitative Analysis of Serum VEGF, CD44s, and MMP-3 Protein in Nasopharyngeal Carcinoma].

Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy

Survival Analyses Correlate Stanniocalcin 2 Overexpression to Poor Prognosis of Nasopharyngeal Carcinomas

Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era

Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.

Exploration and Validation of C-Reactive Protein/Albumin Ratio As a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

[Scd40l, Sp-Selectin and Sicam-1 Plasma Levels in Nasopharyngeal Carcinoma].

ALDH1B1 Predicts Poor Survival for Locally Advanced Nasopharyngeal Carcinoma Patients